J. Scott Daniels

6.9k total citations
170 papers, 4.7k citations indexed

About

J. Scott Daniels is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, J. Scott Daniels has authored 170 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Molecular Biology, 69 papers in Cellular and Molecular Neuroscience and 14 papers in Oncology. Recurrent topics in J. Scott Daniels's work include Neuroscience and Neuropharmacology Research (63 papers), Receptor Mechanisms and Signaling (58 papers) and Pharmacological Receptor Mechanisms and Effects (19 papers). J. Scott Daniels is often cited by papers focused on Neuroscience and Neuropharmacology Research (63 papers), Receptor Mechanisms and Signaling (58 papers) and Pharmacological Receptor Mechanisms and Effects (19 papers). J. Scott Daniels collaborates with scholars based in United States, Belgium and Australia. J. Scott Daniels's co-authors include Craig W. Lindsley, Ryan D. Morrison, Kent S. Gates, Lawrence J. Marnett, P. Jeffrey Conn, Colleen M. Niswender, Carol A. Rouzer, Laura J. Niedernhofer, Rachel E. Greene and Carrie K. Jones and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

J. Scott Daniels

167 papers receiving 4.6k citations

Peers

J. Scott Daniels
László Prókai United States
Michael D. Cameron United States
Douglas J. Kojetin United States
Stefanie D. Krämer Switzerland
David R. Adams United Kingdom
Kevin Beaumont United States
Aren van Waarde Netherlands
Thomas S. Scanlan United States
Gilles Ferry France
Ingebrigt Sylte Norway
László Prókai United States
J. Scott Daniels
Citations per year, relative to J. Scott Daniels J. Scott Daniels (= 1×) peers László Prókai

Countries citing papers authored by J. Scott Daniels

Since Specialization
Citations

This map shows the geographic impact of J. Scott Daniels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Scott Daniels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Scott Daniels more than expected).

Fields of papers citing papers by J. Scott Daniels

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Scott Daniels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Scott Daniels. The network helps show where J. Scott Daniels may publish in the future.

Co-authorship network of co-authors of J. Scott Daniels

This figure shows the co-authorship network connecting the top 25 collaborators of J. Scott Daniels. A scholar is included among the top collaborators of J. Scott Daniels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Scott Daniels. J. Scott Daniels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
DeBoy, Christopher C., et al.. (2025). A Highly Integrated S-Band Transceiver System with Two-Way Doppler Tracking Capability. Digital Commons - USU (Utah State University).
2.
Daniels, J. Scott, et al.. (2024). Safety of flow-controlled ventilation with positive and negative end-expiratory pressure in a swine model of intracranial hypertension. Intensive Care Medicine Experimental. 12(1). 117–117.
3.
Han, Jin H., Alex Chen, Eduard E. Vasilevskis, et al.. (2019). Supratherapeutic Psychotropic Drug Levels in the Emergency Department and Their Association with Delirium Duration: A Preliminary Study. Journal of the American Geriatrics Society. 67(11). 2387–2392. 3 indexed citations
4.
Felts, Andrew S., Alice L. Rodriguez, Ryan D. Morrison, et al.. (2018). Discovery of 4-alkoxy-6-methylpicolinamide negative allosteric modulators of metabotropic glutamate receptor subtype 5. Bioorganic & Medicinal Chemistry Letters. 29(1). 47–50. 4 indexed citations
5.
Sutherland, Jeffrey J., Ryan D. Morrison, J. Scott Daniels, Stephen Milne, & Timothy P. Ryan. (2017). Managing Psychotropic Medications in Complex, Real-World Patients Using Comprehensive Therapeutic Drug Monitoring. ACS Chemical Neuroscience. 8(8). 1641–1644. 7 indexed citations
6.
Gogliotti, Rocco G., Nicole M. Fisher, J. Paige Adams, et al.. (2017). mGlu 7 potentiation rescues cognitive, social, and respiratory phenotypes in a mouse model of Rett syndrome. Science Translational Medicine. 9(403). 63 indexed citations
7.
Sutherland, Jeffrey J., Thomas M. Daly, Karen Jacobs, et al.. (2017). Medication Exposure in Highly Adherent Psychiatry Patients. ACS Chemical Neuroscience. 9(3). 555–562. 5 indexed citations
8.
Byers, Frank W., et al.. (2016). Evaluating the Disposition of a Mixed Aldehyde Oxidase/Cytochrome P450 Substrate in Rats with Attenuated P450 Activity. Drug Metabolism and Disposition. 44(8). 1296–1303. 18 indexed citations
9.
Nickols, Hilary Highfield, Karen J. Gregory, Shaun R. Stauffer, et al.. (2015). VU0477573: Partial Negative Allosteric Modulator of the Subtype 5 Metabotropic Glutamate Receptor with In Vivo Efficacy. Journal of Pharmacology and Experimental Therapeutics. 356(1). 123–136. 28 indexed citations
10.
Duvernay, Matthew T., M. Schulte, Kellie D. Nance, et al.. (2014). Substituted indoles as selective protease activated receptor 4 (PAR-4) antagonists: Discovery and SAR of ML354. Bioorganic & Medicinal Chemistry Letters. 24(19). 4708–4713. 29 indexed citations
11.
Rook, Jerri M., Mohammed Noor Tantawy, M. Sib Ansari, et al.. (2014). Relationship between In Vivo Receptor Occupancy and Efficacy of Metabotropic Glutamate Receptor Subtype 5 Allosteric Modulators with Different In Vitro Binding Profiles. Neuropsychopharmacology. 40(3). 755–765. 33 indexed citations
12.
Felts, Andrew S., Alice L. Rodriguez, Ryan D. Morrison, et al.. (2013). Discovery of VU0409106: A negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety. Bioorganic & Medicinal Chemistry Letters. 23(21). 5779–5785. 27 indexed citations
13.
Manka, Jason, Alice L. Rodriguez, Ryan D. Morrison, et al.. (2013). Octahydropyrrolo[3,4-c]pyrrole negative allosteric modulators of mGlu1. Bioorganic & Medicinal Chemistry Letters. 23(18). 5091–5096. 9 indexed citations
14.
Felts, Andrew S., Alice L. Rodriguez, Daryl F. Venable, et al.. (2013). Substituted 1-Phenyl-3-(pyridin-2-yl)urea Negative Allosteric Modulators of mGlu5: Discovery of a New Tool Compound VU0463841 with Activity in Rat Models of Cocaine Addiction. ACS Chemical Neuroscience. 4(8). 1217–1228. 14 indexed citations
15.
Noetzel, Meredith J., Jerri M. Rook, Paige N. Vinson, et al.. (2011). Functional Impact of Allosteric Agonist Activity of Selective Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 in Regulating Central Nervous System Function. Molecular Pharmacology. 81(2). 120–133. 99 indexed citations
16.
Jones, Carrie K., Michael Bubser, Analisa D. Thompson, et al.. (2011). The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson’s Disease. Journal of Pharmacology and Experimental Therapeutics. 340(2). 404–421. 81 indexed citations
17.
Whitmeyer, Steven J., et al.. (2008). A Pyramid Scheme for Constructing Geologic Maps on Geobrowsers. AGUFM. 2008. 2 indexed citations
18.
Williamson, Mark J., Jonathan L. Blank, Frank J. Bruzzese, et al.. (2006). Comparison of biochemical and biological effects of ML858 (salinosporamide A) and bortezomib. Molecular Cancer Therapeutics. 5(12). 3052–3061. 57 indexed citations
19.
Balani, Suresh K., N. Nagaraja, Mark G. Qian, et al.. (2005). EVALUATION OF MICRODOSING TO ASSESS PHARMACOKINETIC LINEARITY IN RATS USING LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY. Drug Metabolism and Disposition. 34(3). 384–388. 40 indexed citations
20.
Daniels, J. Scott, et al.. (1994). Designing Efficient Container Classes.. Journal of Object-oriented Programming. 7. 22–27. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by László Prókai Breakdown of academic impact, for papers by Michael D. Cameron Breakdown of academic impact, for papers by Douglas J. Kojetin Breakdown of academic impact, for papers by Stefanie D. Krämer Breakdown of academic impact, for papers by David R. Adams Breakdown of academic impact, for papers by Kevin Beaumont Breakdown of academic impact, for papers by Aren van Waarde Breakdown of academic impact, for papers by Thomas S. Scanlan Breakdown of academic impact, for papers by Gilles Ferry Breakdown of academic impact, for papers by Ingebrigt Sylte
Rankless by CCL
2026